Advanced Cell Technology, Inc. Stock OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board
- ^USD	-

16-02-10	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
16-01-22	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
15-12-28	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
15-12-03	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
15-11-11	OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	BU

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	2015-02-02

Director	Title	Age	Since
Toru Yoshimitsu BRD	Director/Board Member	63	-
Masaaki Hirano BRD	Director/Board Member	59	-
Percival Barretto-Ko BRD	Director/Board Member	53	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+4.16%	-0.36%	+49.37%	+94.17%	74.46B
ARGENX SE	-0.61%	+0.69%	+36.36%	+82.72%	60.14B
LONZA GROUP AG	-2.54%	-0.21%	+6.34%	+31.72%	48.15B
IQVIA HOLDINGS INC.	-3.02%	-2.67%	+37.26%	+32.51%	44.25B
REVOLUTION MEDICINES, INC.	+0.31%	+7.94%	+340.88%	+643.82%	43.99B
BEONE MEDICINES AG	-1.96%	-1.71%	+5.30%	+99.46%	41.61B
CELLTRION, INC.	+3.32%	+3.49%	+11.18%	+51.23%	29.97B
WUXI BIOLOGICS (CAYMAN) INC.	+4.77%	+6.16%	+36.77%	+22.78%	29.31B
INSMED INCORPORATED	-4.86%	-8.24%	-24.60%	+330.06%	24.93B
Average	-0.05%	+1.97%	+55.43%	+154.28%	44.09B
Weighted average by Cap.	+0.17%	+1.83%	+60.06%	+145.78%

Employees

Sector